195 related articles for article (PubMed ID: 37906280)
21. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
[TBL] [Abstract][Full Text] [Related]
22. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
[TBL] [Abstract][Full Text] [Related]
23. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers.
Green AR; Aleskandarany MA; Ali R; Hodgson EG; Atabani S; De Souza K; Rakha EA; Ellis IO; Madhusudan S
Cancer Immunol Res; 2017 Apr; 5(4):292-299. PubMed ID: 28254786
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
25. Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.
Alli E; Sharma VB; Sunderesakumar P; Ford JM
Cancer Res; 2009 Apr; 69(8):3589-96. PubMed ID: 19351835
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM.
Kim SY; Rhee JG; Song X; Prochownik EV; Spitz DR; Lee YJ
PLoS One; 2012; 7(11):e50423. PubMed ID: 23185620
[TBL] [Abstract][Full Text] [Related]
27. DNA repair and damage pathways in breast cancer development and therapy.
Majidinia M; Yousefi B
DNA Repair (Amst); 2017 Jun; 54():22-29. PubMed ID: 28437752
[TBL] [Abstract][Full Text] [Related]
28. Liver- and Microbiome-derived Bile Acids Accumulate in Human Breast Tumors and Inhibit Growth and Improve Patient Survival.
Tang W; Putluri V; Ambati CR; Dorsey TH; Putluri N; Ambs S
Clin Cancer Res; 2019 Oct; 25(19):5972-5983. PubMed ID: 31296531
[TBL] [Abstract][Full Text] [Related]
29. DNA damage repair in breast cancer and its therapeutic implications.
Ali R; Rakha EA; Madhusudan S; Bryant HE
Pathology; 2017 Feb; 49(2):156-165. PubMed ID: 28034453
[TBL] [Abstract][Full Text] [Related]
30. MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.
Yang RM; Nanayakkara D; Kalimutho M; Mitra P; Khanna KK; Dray E; Gonda TJ
Oncogene; 2019 Jun; 38(26):5239-5249. PubMed ID: 30971760
[TBL] [Abstract][Full Text] [Related]
31. Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy.
Pfefferle AD; Spike BT; Wahl GM; Perou CM
Breast Cancer Res Treat; 2015 Jan; 149(2):425-37. PubMed ID: 25575446
[TBL] [Abstract][Full Text] [Related]
32. JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer.
Mocavini I; Pippa S; Licursi V; Paci P; Trisciuoglio D; Mannironi C; Presutti C; Negri R
Cancer Sci; 2019 Apr; 110(4):1232-1243. PubMed ID: 30588710
[TBL] [Abstract][Full Text] [Related]
33. A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens.
Keimling M; Kaur J; Bagadi SA; Kreienberg R; Wiesmüller L; Ralhan R
Int J Cancer; 2008 Aug; 123(3):730-6. PubMed ID: 18491400
[TBL] [Abstract][Full Text] [Related]
34. DNA damage uncouples the mitogenic response to IGF-I in MCF-7 malignant breast cancer cells by switching the roles of PI3 kinase and p21WAF1/Cip1.
Clark MA; Perks CM; Winters ZE; Holly JM
Int J Cancer; 2005 Sep; 116(4):506-13. PubMed ID: 15818613
[TBL] [Abstract][Full Text] [Related]
35. Targeting DNA Damage Response in Prostate and Breast Cancer.
Wengner AM; Scholz A; Haendler B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158305
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer.
Li C; Yu S; Chen J; Hou Q; Wang S; Qian C; Yin S
Front Immunol; 2023; 14():1127982. PubMed ID: 37033959
[TBL] [Abstract][Full Text] [Related]
37. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.
Wang H; Xiang D; Liu B; He A; Randle HJ; Zhang KX; Dongre A; Sachs N; Clark AP; Tao L; Chen Q; Botchkarev VV; Xie Y; Dai N; Clevers H; Li Z; Livingston DM
Cell; 2019 Jun; 178(1):135-151.e19. PubMed ID: 31251913
[TBL] [Abstract][Full Text] [Related]
38. Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast.
Beca F; Lee SSK; Pareja F; Da Cruz Paula A; Selenica P; Ferrando L; Gularte-Mérida R; Wen HY; Zhang H; Guerini-Rocco E; Rakha EA; Weigelt B; Reis-Filho JS
Histopathology; 2019 Dec; 75(6):931-937. PubMed ID: 31361912
[TBL] [Abstract][Full Text] [Related]
39. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
Santarpia L; Iwamoto T; Di Leo A; Hayashi N; Bottai G; Stampfer M; André F; Turner NC; Symmans WF; Hortobágyi GN; Pusztai L; Bianchini G
Oncologist; 2013; 18(10):1063-73. PubMed ID: 24072219
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
